2Y3 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Bionano Genomics Inc

Watchlist Manager

Watchlist

Price: 0.4389 EUR -16.62%

Market Cap: €134.7m

B	Bionano Genomics Inc F:2Y3	US
M	Mongolian Mining Corp F:29X2	MN
M	Matsui Securities Co Ltd XMUN:MTW	JP
A	Assured Guaranty Ltd F:DHU	BM
S	Solargiga Energy Holdings Ltd XMUN:3FV	HK
E	ELL Environmental Holdings Ltd F:6EL	CN
	Canadian Gold Corp F:8S8	CA
	Olympus Corp F:OLY1	JP

Profitability Summary

Bionano Genomics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Sustainable 3Y Average Gross Margin

25%

Gross Margin is Increasing

25% > 48%

Negative Operating Margin

-107%

Negative 3Y Average Operating Margin

-235%

Operating Margin is Increasing

-466% > -107%

Negative Net Margin

-107%

Negative 3Y Average Net Margin

-355%

Net Margin is Increasing

-465% > -107%

Negative Free Cash Flow Margin

-68%

Negative 3Y Average Free Cash Flow Margin

-197%

Free Cash Flow Margin is Increasing

-428% > -68%

Negative ROE

-84%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-79%

ROIC is Increasing

-96% > -75%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Sustainable 3Y Average Gross Margin

25%

Gross Margin is Increasing

25% > 48%

Negative Operating Margin

-107%

Negative 3Y Average Operating Margin

-235%

Operating Margin is Increasing

-466% > -107%